1. Home
  2. ORIC vs UPXI Comparison

ORIC vs UPXI Comparison

Compare ORIC & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • UPXI
  • Stock Information
  • Founded
  • ORIC 2014
  • UPXI 2018
  • Country
  • ORIC United States
  • UPXI United States
  • Employees
  • ORIC N/A
  • UPXI N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • ORIC Health Care
  • UPXI Health Care
  • Exchange
  • ORIC Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • ORIC 362.9M
  • UPXI 356.9M
  • IPO Year
  • ORIC 2020
  • UPXI 2021
  • Fundamental
  • Price
  • ORIC $11.10
  • UPXI $5.39
  • Analyst Decision
  • ORIC Strong Buy
  • UPXI
  • Analyst Count
  • ORIC 9
  • UPXI 0
  • Target Price
  • ORIC $18.29
  • UPXI N/A
  • AVG Volume (30 Days)
  • ORIC 949.2K
  • UPXI 4.2M
  • Earning Date
  • ORIC 08-11-2025
  • UPXI 05-16-2025
  • Dividend Yield
  • ORIC N/A
  • UPXI N/A
  • EPS Growth
  • ORIC N/A
  • UPXI N/A
  • EPS
  • ORIC N/A
  • UPXI N/A
  • Revenue
  • ORIC N/A
  • UPXI $16,562,327.00
  • Revenue This Year
  • ORIC N/A
  • UPXI $299.03
  • Revenue Next Year
  • ORIC N/A
  • UPXI N/A
  • P/E Ratio
  • ORIC N/A
  • UPXI N/A
  • Revenue Growth
  • ORIC N/A
  • UPXI 1378.83
  • 52 Week Low
  • ORIC $3.90
  • UPXI $1.90
  • 52 Week High
  • ORIC $14.67
  • UPXI $22.57
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 66.82
  • UPXI 44.83
  • Support Level
  • ORIC $10.42
  • UPXI $2.73
  • Resistance Level
  • ORIC $11.50
  • UPXI $3.47
  • Average True Range (ATR)
  • ORIC 0.62
  • UPXI 0.69
  • MACD
  • ORIC -0.03
  • UPXI 0.14
  • Stochastic Oscillator
  • ORIC 83.30
  • UPXI 36.97

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.

Share on Social Networks: